CN103462965B - Incarviatone A在制备促胰岛素分泌药物中的应用 - Google Patents
Incarviatone A在制备促胰岛素分泌药物中的应用 Download PDFInfo
- Publication number
- CN103462965B CN103462965B CN201310432529.6A CN201310432529A CN103462965B CN 103462965 B CN103462965 B CN 103462965B CN 201310432529 A CN201310432529 A CN 201310432529A CN 103462965 B CN103462965 B CN 103462965B
- Authority
- CN
- China
- Prior art keywords
- preparation
- incarviatone
- incarviatonea
- insulinotropic hormone
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 230000029142 excretion Effects 0.000 title claims abstract description 9
- 229940088597 hormone Drugs 0.000 title claims abstract description 9
- 239000005556 hormone Substances 0.000 title claims abstract description 9
- 230000002473 insulinotropic effect Effects 0.000 title claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 230000003914 insulin secretion Effects 0.000 abstract description 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 5
- 210000004153 islets of langerhan Anatomy 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000012528 insulin ELISA Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310432529.6A CN103462965B (zh) | 2013-09-22 | 2013-09-22 | Incarviatone A在制备促胰岛素分泌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310432529.6A CN103462965B (zh) | 2013-09-22 | 2013-09-22 | Incarviatone A在制备促胰岛素分泌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103462965A CN103462965A (zh) | 2013-12-25 |
CN103462965B true CN103462965B (zh) | 2015-12-09 |
Family
ID=49788163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310432529.6A Active CN103462965B (zh) | 2013-09-22 | 2013-09-22 | Incarviatone A在制备促胰岛素分泌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103462965B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7429670B2 (en) * | 2003-08-27 | 2008-09-30 | The Trustees Of Columbia University In The City Of New York | Synthesis of derivatives of ginkgolide C |
EP1939166A1 (en) * | 2006-12-19 | 2008-07-02 | InterMed Discovery GmbH | Plants extracts for use in brain modulation |
-
2013
- 2013-09-22 CN CN201310432529.6A patent/CN103462965B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103462965A (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103462965B (zh) | Incarviatone A在制备促胰岛素分泌药物中的应用 | |
CN103463038B (zh) | Lycojaponicumin A在制备促胰岛素分泌药物中的应用 | |
CN103463077B (zh) | Lycojaponicumin C在制备促胰岛素分泌药物中的应用 | |
CN103463031B (zh) | Lycojaponicumin B在制备促胰岛素分泌药物中的应用 | |
CN103356593B (zh) | Chukrasone B在制备促胰岛素分泌药物中的应用 | |
CN102988395B (zh) | Houttuynoid E在制备促胰岛素分泌药物中的应用 | |
CN102872039B (zh) | Gypensapogenin B在制备促胰岛素分泌药物中的应用 | |
CN103127083A (zh) | Aphanamixoid A在促胰岛素分泌药物中的应用 | |
CN102988381A (zh) | Houttuynoid A在制备促胰岛素分泌药物中的应用 | |
CN103356540A (zh) | Sarcaboside A在促胰岛素分泌药物中的应用 | |
CN104224798B (zh) | 乔木烷型三萜类化合物抗代谢综合征的应用及所制备的药物 | |
CN103356565A (zh) | Sarcaboside B在促胰岛素分泌药物中的应用 | |
CN104177302B (zh) | 格列吡嗪衍生物及其制备方法和应用 | |
CN103372020A (zh) | Chukrasone A在促胰岛素分泌药物中的应用 | |
CN103127152A (zh) | Gypensapogenin A在促胰岛素分泌药物中的应用 | |
CN103127068A (zh) | Eryngiolide A在促胰岛素分泌药物中的应用 | |
CN103655552B (zh) | Manzamenone O在治疗胰腺癌药物中的应用 | |
CN104173335A (zh) | 佛手柑素在制备防治糖尿病药物中的应用 | |
CN103405407B (zh) | 一种化合物在制备治疗胰腺癌药物中的应用 | |
CN102716122B (zh) | 15-苄亚基-14-脱氧-11,12-脱氢穿心莲内酯衍生物在制备治疗糖尿病药物中的应用 | |
CN103319449B (zh) | 1,2,3,6,7-五羟基二苯吡酮衍生物及其制备方法和其应用 | |
CN103638016B (zh) | Manzamenone O在治疗直肠癌药物中的应用 | |
CN103463050B (zh) | Lycojaponicumin A在制备治疗胃癌药物中的应用 | |
CN103463032B (zh) | Lycojaponicumin A在制备治疗胰腺癌药物中的应用 | |
CN102872010B (zh) | Aphanamixoid A在治疗卵巢癌药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Hongli Inventor before: Jiang Chunping Inventor before: Huang Rong |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151103 Address after: 325011, building 1112, building A, 209 Wenchang Road, hi tech Zone, Longwan District, Zhejiang, Wenzhou Applicant after: Wenzhou Chengqiao Technology Co.,Ltd. Address before: Metro Technology Building No. 69 Olympic Avenue in Jianye District of Nanjing city in Jiangsu province 210019 01 5 storey buildings Applicant before: Nanjing Guangkangxie Biomedical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180823 Address after: 529300 1 Harbour City villa area, Guangming East Road, Changsha, Kaiping, Guangdong. Patentee after: Kuang Wenzhan Address before: 325011 room 1112, building A, 209 Wenchang Road, hi tech Zone, Longwan District, Wenzhou, Zhejiang. Patentee before: Wenzhou Chengqiao Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181108 Address after: 529300 Industrial Development Zone, Sha Tang Town, Kaiping, Guangdong Patentee after: Guangdong Bio Pharmaceutical Co., Ltd. Address before: 529300 1 Harbour City villa area, Guangming East Road, Changsha, Kaiping, Guangdong. Patentee before: Kuang Wenzhan |
|
CP02 | Change in the address of a patent holder |
Address after: 529300 No. 4-1, Shatang Town, Kaiping, Jiangmen City, Guangdong Province Patentee after: Guangdong Bio Pharmaceutical Co., Ltd. Address before: 529300 Industrial Development Zone, Sha Tang Town, Kaiping, Guangdong Patentee before: Guangdong Bio Pharmaceutical Co., Ltd. |
|
CP02 | Change in the address of a patent holder |